Predict your next investment

noven.com

See what CB Insights has to offer

Partners & Customers

5

About Noven Pharmaceuticals

Noven Pharmaceuticals Headquarter Location

405 Lexington Avenue

New York, New York, 10174-6300,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Noven Pharmaceuticals News

Hormone Replacement Therapy Market Outlook 2017-2027 | Analysis and Forecast Report with Key Players- Merck & co., BioSante Pharmaceuticals and Amgen, QuatRx Pharmaceuticals, Noven Pharmaceuticals.

Jun 23, 2021

| Analysis and Forecast Report with Key Players- Merck & co., BioSante Pharmaceuticals and Amgen, QuatRx Pharmaceuticals, Noven Pharmaceuticals. Estrogen and progesterone are female hormones that play important roles in a woman’s body. Falling levels cause a range of physical and emotional symptoms, including hot flushes, mood swings and vaginal dryness. The aim of hormone replacement therapy is to restore female hormone levels, allowing the body to function normally again. Impact of COVID-19 on the Healthcare Industry The COVID-19 pandemic has causedsevere impacts on the global economy at various levels and which can be seen onthe Healthcare industry as well. The thriving market of health care researchand development is expected to exhibit a steep decline in the sales during thelockdown period owing to the shutdown of the manufacturing units, acuteshortage in the supply of raw materials and absence of potential manpower. Itcan be deduced from the current situations brought about by the pandemic thatthe production, and supply chain activities have experienced minor hurdles.However, the market is projected to gradually recover post-COVID-19, which willpresent attractive opportunities for sales across various regions of the worldin the following years. Future Market Insights (FMI) adopteda multidisciplinary approach during the pandemic-era to focus on the growth anddevelopment of the HormoneReplacement Therapy Market . Thestudy features insights on the current growth dynamics and the major revenuereforms prevailing in the market as along with the key takeaways over theforecast. The team of analysts at Future MarketInsights are focussing on research and market study to produce different HormoneReplacement Therapy Market forecasts and predictions at both national andinternational levels. They have considered several leads of informationpertaining to the industry like market figures and merger estimations to assessand produce reliable and informative insights on the Hormone ReplacementTherapy Market. To remain ‘ahead’ of your competitors, Ask aQuestion >> https://www.futuremarketinsights.com/ask-question/rep-gb-3871 Key Players The writer will create content on thegeneral strategies of market players. And then will write the key players inthe market are: Bayer AG, Pfizer, Merck & co., BioSante Pharmaceuticals andAmgen, QuatRx Pharmaceuticals, Noven Pharmaceuticals Segmentation The report provides insights on the important highlights and currenttrends prevailing in the market. This helps the readers to gain a deeperunderstanding and form an unbiased opinion on the market. Numeroussegmentations have been provided for this market based on: Based on TherapyType, Fullin-depth analysis of the parent market The analysts at FMI are dedicated toprovide insights after extensive research and study. The study also includesestimations, projections and evaluation of the market dynamics. Importantchanges in market dynamics The report has beencreated after detailed and exhaustive studies by the analysts at FMI takingseveral factors into consideration like monetary, ecological, social,mechanical, and political status of a particular demography. They study the keydata to assess the revenue and production of manufacturers across variousregions. The report also covers an in-depth analysis ofthe key changes in market dynamics in the recent past and the near future. Segmentationdetails of the market Emerging segments and regional markets Queries Solved What is the size of the overall HormoneReplacement Therapy Market in the Healthcare Industry and its segments? What are the key segments andsub-segments in the market? What are the key drivers, restraints,opportunities, and challenges of the Hormone Replacement Therapy Market in theHealthcare Industry, and how they are expected to impact the market? What are the attractive investmentopportunities within the Hormone Replacement Therapy Market in the HealthcareIndustry? What is the Hormone ReplacementTherapy Market in the Healthcare Industry size at the regional andcountry-level? What are the key market playersfocusing on? What are the strategies for growthadopted by the key players in Hormone Replacement Therapy Market in theHealthcare Industry? What are the recent trends in HormoneReplacement Therapy Market in the Healthcare Industry? (M&A, partnerships,new product developments, expansions)? What are the challenges to the HormoneReplacement Therapy Market in the growth of the Healthcare Industry? What are the key market trendsimpacting the growth of the Hormone Replacement Therapy Market in theHealthcare Industry? To receive extensive list of importantregions, ask for TOC here >>  https://www.futuremarketinsights.com/toc/rep-gb-3871 Table of Content MarketBackground     Reasons to Buythe report We provide authentic and detailed ananalysis on various market trends to enable businesses to make informed andbeneficial decisions to attain competitive edge over key players. Our analysts provide detailed marketsegmentation along with meaningful insights and extensive reports that othercompanies fail to include. The report includes accurate analysisof the market and the current developing trends affecting the growth. FMI speaks tostakeholders across the spectrum, including C-level executives, distributors,product manufacturers, industry experts. This ensures that the data collected is fromhighly reliable sources. Explore Wide-ranging Coverage of FMI’s HealthcareLandscape Transradial Closure Devices Market – According to Future Market Insights (FMI), the demand from hospitals,independent catheterization centers, and healthcare clinics will continuerising. Spurred by this, the global transradial closure devices market is setto grow by 6.5% CAGR during the forecast period from the year 2020 to 2030. In Vitro FertilizationBanking Services Market – The in vitro fertilization banking services market,despite undergoing a temporary period of lull due to COVID-19 outbreak, islikely to have an impressive growth trajectory between 2020 and 2030. Cryopreservationfor In-vitro Fertilization (IVF) Market – According to analysis by Future Market Insights (FMI), cryopreservationfor IVF market surpassed a valuation of US$ 339 million in 2019. Themarket is set to reflect an impressive 10.2% CAGR through 2030. About FMI        Future Market Insights (FMI) is a leading provider of marketintelligence and consulting services, serving clients in over 150countries. FMI  isheadquartered in Dubai, the global financial capital, and has delivery centersin the U.S. and India. FMI’s latest  marketresearch reports  and industry analysis help businesses navigatechallenges and make critical decisions with confidence and clarity amidstbreakneck competition. Our customized and syndicated market research reportsdeliver actionable insights that drive sustainable growth. A team of expert-ledanalysts at FMI continuously tracks emerging trends and events in a broad rangeof industries to ensure that our clients prepare for the evolving needs oftheir consumers. ContactUs

Noven Pharmaceuticals Acquisitions

2 Acquisitions

Noven Pharmaceuticals acquired 2 companies. Their latest acquisition was JDS Pharmaceuticals on August 15, 2007.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

8/15/2007

Private Equity

$99M

$62M

Acquired

1

8/9/2007

Series A

Subscribe to see more

$99M

$99M

Subscribe to see more

0

Date

8/15/2007

8/9/2007

Investment Stage

Private Equity

Series A

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$62M

$99M

Note

Acquired

Subscribe to see more

Sources

1

0

Noven Pharmaceuticals Partners & Customers

5 Partners and customers

Noven Pharmaceuticals has 5 strategic partners and customers. Noven Pharmaceuticals recently partnered with Shionogi Inc. on January 1, 2014.

Date

Type

Business Partner

Country

News Snippet

Sources

1/13/2014

Partner

Shionogi Inc.

United States

Announces Co-Promotion Agreement with Noven Pharmaceuticals For Brisdelle™ (Paroxetine) Capsules - Shionogi Inc. A Discover

FLORHAM PARK , N.J. -- -- Shionogi Inc. today announced that it has entered into an exclusive , multi-year agreement with Noven Pharmaceuticals to co-promote Brisdelle .

1

2/21/2007

Licensee

Shire

Ireland

Subscribe to see more

Subscribe to see more

10

4/28/2005

Partner

Novartis

Switzerland

Subscribe to see more

Subscribe to see more

10

6/16/2004

Partner

Novartis

Switzerland

Subscribe to see more

Subscribe to see more

10

Licensee

Novartis

Switzerland

Subscribe to see more

Subscribe to see more

10

Date

1/13/2014

2/21/2007

4/28/2005

6/16/2004

Type

Partner

Licensee

Partner

Partner

Licensee

Business Partner

Shionogi Inc.

Shire

Novartis

Novartis

Novartis

Country

United States

Ireland

Switzerland

Switzerland

Switzerland

News Snippet

Announces Co-Promotion Agreement with Noven Pharmaceuticals For Brisdelle™ (Paroxetine) Capsules - Shionogi Inc. A Discover

FLORHAM PARK , N.J. -- -- Shionogi Inc. today announced that it has entered into an exclusive , multi-year agreement with Noven Pharmaceuticals to co-promote Brisdelle .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Noven Pharmaceuticals Team

1 Team Member

Noven Pharmaceuticals has 1 team member, including former Chief Executive Officer, Robert C Strauss.

Name

Work History

Title

Status

Robert C Strauss

Chief Executive Officer

Former

Name

Robert C Strauss

Work History

Title

Chief Executive Officer

Status

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.